weight loss plateau strategies glp-1 medications maintenance after discontinuation of therapies Frontiers | GLP-1 agonists and

- Assisting the pancreas in releasing the appropriate amount of insulin

Introduction to organic practices

Presently, the Australian Diabetes Society (ADS) and ANZCA Perioperative Diabetes and Hyperglycaemia Guidelines (November 2022) provide the universal recommendation to withhold all non-insulin antihyperglycaemics on day of surgery, including GLP-1 agonists, with SGLT2 inhibitors to be withheld 2 days prior to surgery

The most common reasons for resistance to initiate insulin were restrictiveness (insulin therapy would restrict my life), low self-efficacy (I am not confident I could handle the demands of insulin therapy), personal failure (insulin therapy would mean I had failed) and permanence (once you start insulin you can never quit) [13]